| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |